CONTACT US

Our Address

Science Avenue, High-tech Zone, Zhengzhou City, Henan Province, China

  • List of Top Pharma Companies in Asia Best Pharmaceutical ...

    Southeast Asia alone is expected to generate $40 billion in pharmaceutical sales by 2020. The Asia Pacific is the third-largest pharmaceutical market in the world after North America and Europe, with generics being the major driver for the pharmaceutical industry in this region. Below given is the List of Top Pharma Companies in Asia.

  • ASEAN Pharma Report: Opportunities Threats 2020 and Beyond

    ASEAN Pharma Report CPhI South East Asia 2 Opportunities and threats 2020 and beyond Overview Aging populations are transforming pharmaceutical markets in Southeast Asia. Growing healthcare expenditures bring opportunities for pharma, as well as new complexities and challenges. Wider competition in pharma manufacturing across the region adds to the mix creating a dynamic

  • ASEAN Pharma Market Report Global Pharma Insights

    Aging populations are transforming pharmaceutical markets in Southeast Asia. Growing healthcare expenditures bring opportunities for pharma, but change also brings new complexities and challenges. Wider competition in pharma manufacturing across the region adds to the mix creating a dynamic environment to which industry players must adapt. Notable challenges include accessing imports of

  • A Pharma Playbook for Success in Southeast Asia

    23/08/2016  The pharmaceutical sector of the health care industry in Southeast Asia has seen strong growth in recent years, fueled by an expanding middle class, a rise in personal income (an estimated 6% CAGR from 2015 through 2030), and a surge in private insurance coverage. (See Exhibit 1.) In addition, less healthy lifestyles have led to an increase in costly, chronic disorders, such as cardiovascular ...

  • Pharmaceuticals outlook in Southeast Asia

    15/08/2018  Pharmaceutical Outlook in Southeast Asia Oficom Indonesia 2. Pharmaceuticals in Southeast Asia The manufacture of basic pharmaceutical products and preparations, and the wholesaling of pharmaceutical goods are facing the intensity of competition and changing market dynamics. According to the ¨Asian competition barometer on pharmaceuticals¨ developed by The

  • Untapped Opportunities in Southeast Asia Pharma Articles

    Southeast Asia is a growing pharmaceutical market with an increase in clinical trials in recent years. With a population of about 620 million and a total area of 4.5 million kilometres it contains the region’s well-recognised study destinations of Malaysia, Singapore and Thailand, who are also members of PIC/S the Pharmaceutical Inspection Co-operation Scheme.

  • Pharmaceuticals outlook in Southeast Asia

    15/08/2018  Pharmaceutical Outlook in Southeast Asia Oficom Indonesia 2. Pharmaceuticals in Southeast Asia The manufacture of basic pharmaceutical products and preparations, and the wholesaling of pharmaceutical goods are facing the intensity of competition and changing market dynamics. According to the ¨Asian competition barometer on pharmaceuticals¨ developed by The

  • Pharmaceutical Growth in Southeast Asia and Gulf ...

    01/12/2016  The proposed U.S. withdrawal from the TPP will not adversely affect the pharmaceutical industry in Southeast Asia. Instead, it will probably actually boost the industry by supporting the companies which produce generic medication, making low-cost treatments more readily available. Since the GCC follows regulations much like Europe, Canada, and the United States, the withdrawal won’t

  • A Pharma Playbook for Success in Southeast Asia

    23/08/2016  The pharmaceutical sector of the health care industry in Southeast Asia has seen strong growth in recent years, fueled by an expanding middle class, a rise in personal income (an estimated 6% CAGR from 2015 through 2030), and a surge in private insurance coverage. (See Exhibit 1.) In addition, less healthy lifestyles have led to an increase in costly, chronic disorders, such as cardiovascular ...

  • Asia's Emerging Pharmaceutical Markets - China,

    Southeast Asia is also the world’s fastest-growing pharmaceutical market. While most analysts expect the worldwide market for pharmaceuticals to grow just 5-6% / year through 2000, the Chinese and Southeast Asian markets are predicted to experience double-digit growth over the same period, continuing the trend of the past five years (Table 2).

  • Top trends impacting South East Asia’s pharma market –

    With an annual growth rate of 9.1% between 2016 and 2021 in Asian markets, pharmaceutical companies in South East Asia still enjoy high growth in the region and probably some of the highest worldwide. Yet high dependence on out-of-pocket expenses in South East Asia results in a low adoption of high-priced treatments, compared to reasonably well-financed reimbursed markets. While the

  • Asia's Pharma Biotech Festival Phar-East 2020 8 - 9 ...

    Asia's pharma biotech festival - Phar-East is the premier meeting place for senior executives from Asia’s pharma and biotech industry. Toggle navigation. Phar-East 2020 8 - 9 December Resorts World Convention Centre, Singapore. register now ; home; our story. photos; blog; sponsor / exhibit. 2020 sponsors exhibitors; 2020 partners; 2020 floor plan; marketing opportunities; marketing ...

  • CPhI South East Asia Your Key to Southeast Asia Pharma

    Making easy work of entering one of the most promising pharma markets worldwide, CPhI South East Asia is a pharmaceutical event that brings domestic, regional and international pharma professionals together for three days that facilitate global business.

  • Southeast Asia - Wikipedia

    Southeast Asia is bordered to the north by East Asia, to the west by South Asia and the Bay of Bengal, to the east by Oceania and the Pacific Ocean, and to the south by Australia and the Indian Ocean. The region is the only part of Asia that lies partly within the Southern Hemisphere, although the majority of it is in the Northern Hemisphere. In contemporary definition, Southeast Asia consists ...

  • Av Pharma – New Website

    We distribute innovative pharmaceutical products across the world, specialising in the Middle East and the Caribbean. We Simplify. We simplify the process for pharmaceutical manufacturers, offering a full registration, marketing, logistics and distribution service. We Source. We source and supply a vast range of medicines to fulfil market drug shortage including branded, generics and hospital ...

  • PharmEng Asia Regulatory Affairs Services

    PharmEng RA helps manufacturers obtain certification or approval to sell their medical devices and pharmaceutical products in Asia. Through our Asian offices, we can guide you through the language barriers and complex registration processes in China, Indonesia as well as other Southeast Asian countries. Pharmacovigilance Compliance . PharmEng RA leverages on its expert network and

  • CPhI South East Asia Your Key to Southeast Asia Pharma

    Making easy work of entering one of the most promising pharma markets worldwide, CPhI South East Asia is a pharmaceutical event that brings domestic, regional and international pharma professionals together for three days that facilitate global business.

  • Southeast asia - Pharma

    Southeast Asia. Bristol-Myers Squibb extends deal with DKSH in SE Asia. 08-Apr-2014 ...

  • Roquette at CPhI Southeast Asia 2020 Pharma -

    04/03/2020  Roquette helps save and sustain lives as a trusted supplier of excipients and active pharmaceutical ingredients. ... CPhI Southeast Asia 2020 March 2-4. Print: CPhI Southeast Asia 2020. Plant-based excipients and life-saving active ingredients. Bangkok, Thailand July 1, 2020 ...

  • Asia's Emerging Pharmaceutical Markets - China,

    Southeast Asia is also the world’s fastest-growing pharmaceutical market. While most analysts expect the worldwide market for pharmaceuticals to grow just 5-6% / year through 2000, the Chinese and Southeast Asian markets are predicted to experience double-digit growth over the same period, continuing the trend of the past five years (Table 2).

  • Fosun Pharma Sees 'Huge' Opportunities in India,

    17/09/2018  Fosun Pharma, Fosun's pharmaceutical arm, is also stepping up its international ties, recently setting up subsidiaries in the U.S. and Europe to expand overseas research and sales. Fosun Pharma

  • Top trends impacting South East Asia’s pharma market –

    With an annual growth rate of 9.1% between 2016 and 2021 in Asian markets, pharmaceutical companies in South East Asia still enjoy high growth in the region and probably some of the highest worldwide. Yet high dependence on out-of-pocket expenses in South East Asia results in a low adoption of high-priced treatments, compared to reasonably well-financed reimbursed markets. While the

  • A Pharma Playbook for Success in Southeast Asia

    Challenges in Southeast Asia The pharmaceutical sector of the health care industry in Southeast Asia has seen strong growth in recent years, fueled by an expanding middle class, a rise in personal income (an estimated 6% CAGR from 2015 A Pharma Playbook for Success in Southeast Asia 2 through 2030), and a surge in private insur- ance coverage. (See Exhibit 1.) In addition, less healthy ...

  • Report from Southeast Asia Pharmaceutical Technology

    02/06/2013  Southeast Asia is a growing pharmaceutical market. Much like Latin America, the countries of southeast Asia, especially the members of the Association of Southeast Asian Nations (ASEAN: Brunei, Burma, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, and Vietnam), have taken initial steps towards seeking more harmonized regulation of pharmaceutical

  • Overview of healthcare in Southeast Asia - ASEAN UP

    10/02/2016  The State of healthcare in South East Asia – summary. Trends for healthcare in Southeast Asia – slide 3 1. A Snapshot of Healthcare in the Region – slide 4 ASEAN total healthcare spend: over 68 Billion USD – slide 5 ASEAN total healthcare spend as % of GDP by country – slide 6 ASEAN total healthcare spend as % of government expenditure – slide 7

  • EY Life Sciences Report: Asia

    EY Life Sciences Report: Asia. Contents. 2. Market insights. 10. Tax updates: significant developments. 22. Featured articles. 22 Reinventing pharma sales and marketing through digital in India 26 Intelligent automation — will IA provide relief to a sickly pharmaceutical industry? 30 Megatrends in ASEAN markets have health care industry ...

  • Pharma-backed initiative delivers low-cost hep C drugs ...

    18/04/2016  A new program run by charities and academia with the support of pharma is looking to cure 25,000 hep C patients in Africa and Southeast Asia by allowing better access to new drugs.

  • Fosun Pharma Sees 'Huge' Opportunities in India,

    17/09/2018  Fosun Pharma, Fosun's pharmaceutical arm, is also stepping up its international ties, recently setting up subsidiaries in the U.S. and Europe to expand overseas research and sales. Fosun Pharma

  • Roquette at CPhI Southeast Asia 2020 Pharma -

    04/03/2020  Roquette helps save and sustain lives as a trusted supplier of excipients and active pharmaceutical ingredients. ... CPhI Southeast Asia 2020 March 2-4. Print: CPhI Southeast Asia 2020. Plant-based excipients and life-saving active ingredients. Bangkok, Thailand July 1, 2020 ...

  • Indian Pharmaceutical Export for South East Asia,

    pharmaceutical exporter in south east asia Actiza pharmaceuticals have been a major exporter for Southeast Asia for many years. Our elaborate export chain exists in all the major Southeast Asian countries including Indonesia, Philippines, Vietnam, and many more.

  • A Pharma Playbook for Success in Southeast Asia

    Challenges in Southeast Asia The pharmaceutical sector of the health care industry in Southeast Asia has seen strong growth in recent years, fueled by an expanding middle class, a rise in personal income (an estimated 6% CAGR from 2015 A Pharma Playbook for Success in Southeast Asia 2 through 2030), and a surge in private insur- ance coverage. (See Exhibit 1.) In addition, less healthy ...

  • Southeast Asia Pharma and Healthcare Sector Report

    Southeast Asia Pharma and Healthcare Sector Report 2019/2020 An EMIS Insights Industry Report EMIS is an ISI Emerging Markets Group Company Date: May 2019 Pages: 72 Available in: English . With 1.4bn population each as of 2017, India and China are the most numerous countries out of the six forming the focus of this report. However, the two countries differ widely in terms of per capita GDP ...

  • Japan's Owndays woos Southeast Asian fashionistas with ...

    Health Care Pharma Industrials Property Services ... [$46] in Southeast Asia," said Owndays President Shuji Tanaka, who cites how average monthly pay in the region reaches less than $1,000 or ...

  • Southeast Asia: An Emerging Market With Booming

    Southeast Asia: An Emerging Market With Digital Growth Potential. When it comes to economic growth in Asia, the focus often falls on China. However, while China’s story is continually staggering in its scale, the Chinese economic powerhouse is only a part of a much wider story in Asia. Just like China, rapidly-growing countries like Vietnam, Indonesia, Cambodia, and The Philippines are also ...

  • The State of Healthcare in Southeast Asia - The Economist ...

    17/03/2014  Southeast Asia truly is going private and there are big opportunities for private healthcare providers and health related firms. In conclusion, from both the public and private sector, demand is growing. The future of healthcare in Southeast Asia is exciting and the journey is just beginning. In the years ahead, Southeast Asia will have to deal with ‘new’ healthcare problems: an increase ...

  • Asia's 7 Largest Emerging Market Drugmakers Seasia.co

    24/09/2017  PT Kalbe Farma Tbk, based in Indonesia, is southeast Asia’s largest listed pharmaceutical company. Kalbe Farma’s main business focus rests on four divisions: prescription pharmaceuticals, consumer health products, nutritional goods, and distribution and logistics. The company derives 95% of its revenues from Indonesia. ROCE for the company’s stock was reported at